Levetiracetam in pharma franchise in Meghalaya

Levetiracetam in PCD pharma franchise in Shimla

Levetiracetam in top pharma company in Jaipur

Levetiracetam in pcd pharma supplier in Lucknow

Levetiracetam in phama franchise company in India
Levetiracetam in phama distributor in Kanpur

Home/Products /levetiracetam-1500mg-infusion-infusion

Lapcetam RTU 1500 Infusion

Composition : Levetiracetam (1500mg) Infusion

Dosage Form : Infusion

Packaging Type : Vial

Packaging : 100ml

Price : ₹1/-

Lapcetam RTU 1500 Infusion is a ready-to-use intravenous formulation containing Levetiracetam (1500 mg), specifically designed for the rapid management of epilepsy in critical settings. This antiepileptic medication is primarily utilized when oral administration is not feasible, such as during acute seizures or when patients are unconscious or unable to swallow.

Levetiracetam acts by modulating synaptic vesicle protein 2A, which helps stabilize neuronal activity and suppress abnormal electrical discharges in the brain. Its intravenous route ensures quick onset of action, making it ideal for status epilepticus, sudden exacerbations of seizures, or transitioning patients from oral antiepileptic medications during surgery or hospitalization.

Lapcetam RTU 1500 Infusion is premixed and ready for immediate administration, reducing preparation time and ensuring accuracy in dosage. Its well-tolerated profile and minimal drug-drug interactions make it a reliable choice in emergency care or intensive care units. This formulation can also be seamlessly integrated into a patient's long-term epilepsy management plan when oral medications are resumed.

Read More

About the Product

Lapcetam RTU 1500 Infusion is a ready-to-use intravenous formulation containing Levetiracetam (1500 mg), specifically designed for the rapid management of epilepsy in critical settings. This antiepileptic medication is primarily utilized when oral administration is not feasible, such as during acute seizures or when patients are unconscious or unable to swallow.

Levetiracetam acts by modulating synaptic vesicle protein 2A, which helps stabilize neuronal activity and suppress abnormal electrical discharges in the brain. Its intravenous route ensures quick onset of action, making it ideal for status epilepticus, sudden exacerbations of seizures, or transitioning patients from oral antiepileptic medications during surgery or hospitalization.

Lapcetam RTU 1500 Infusion is premixed and ready for immediate administration, reducing preparation time and ensuring accuracy in dosage. Its well-tolerated profile and minimal drug-drug interactions make it a reliable choice in emergency care or intensive care units. This formulation can also be seamlessly integrated into a patient's long-term epilepsy management plan when oral medications are resumed.

Common side effects may include drowsiness, dizziness, fatigue, and irritability. Rare adverse effects may include mood changes, allergic reactions, or injection site discomfort.

Lapcetam RTU 1500 Infusion is indicated for the management of status epilepticus and other acute seizure conditions when oral administration of Levetiracetam is not possible.

This medication should only be administered under medical supervision in a healthcare facility. Avoid abrupt discontinuation to prevent rebound seizures. Report any adverse effects or unusual symptoms to the healthcare provider promptly.

Store at a temperature not exceeding 25°C. Protect from light and freezing. Use the infusion immediately after opening.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation